Type 2 & other diabetes

The Use of Semaglutide in Patients With Renal Failure-A Retrospective Cohort Study

Endocr PractPublished Retrospective cohort study

Authors' conclusion

Based on this retrospective study semaglutide appears to be tolerated by most individuals with CKD 4 or greater despite associated gastrointestinal side effects similar to those observed in patients with better kidney function and leads to an improvement of glycemic control and insulin discontinuation in patients with T2DM. Modest weight loss (approximately 4.6% of the total body weight) was observed on the prescribed doses. Larger prospective randomized studies are needed to comprehensively assess the risks and benefits of semaglutide in patients with CKD 4 or greater and obesity.

Study context

Population
Patients with chronic kidney disease (CKD) 4 or greater (estimated glomerular filtration rate (eGFR) 15–29 or <15 mL/min/1.73 m², or on dialysis) started on semaglutide, January 2018–January 2023; 96.0% T2D, 53.9% male, mean age 66.8 y (SD 11.5), mean BMI 36.2 (SD 7.5)
Participants
76 patients
Outcome
Safety and efficacy of semaglutide
Methodological detailssingle-group, electronic medical record based, consecutive patients
  • Single-group
  • Electronic medical record based
  • Consecutive patients

Main finding

As reported in the abstract

No adverse effects reported
48 (63.1%)
Mean weight decreased from 106.2 (SD 24.2) to 101.3 (SD 27.3) kg
P < .001
Mean hemoglobin A1c (HbA1c) decreased from 8.0% (SD 1.7) to 7.1% (SD 1.3)
P < .001

Observational data: associations, not effects.

Further findings

OutcomeValues
Insulin discontinuation after starting semaglutide (T2D)Semaglutide 16%
Duration of semaglutide treatmentSemaglutide median 17.4 (IQR 0.43–48.8) months

Maximum prescribed dose

1 mg injectable
28 (45.2%)
14 mg oral
2 (14.2%)

Safety

Semaglutide discontinuation

Adverse effects as primary reason for discontinuation
37.0%
Most common complaints: nausea, vomiting and abdominal pain

Original publication

The Use of Semaglutide in Patients With Renal Failure-A Retrospective Cohort Study. Endocr Pract. Published 16 July 2024. doi:10.1016/j.eprac.2024.07.008

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.